← Back to headlines
Eli Lilly and Weight Loss Drugs Discussed by Jim Cramer
Jim Cramer shares his insights on Eli Lilly (LLY) and the growing market for weight loss drugs.
18 Feb, 17:50 — 18 Feb, 17:50
ℹOnly 1 source covers this story
Read at source (1 outlet)
Related Stories
Ethereum Staking Demand Falls, Raising Concerns for ETH Price
8m ago
Hong Kong Considers Yuan Internationalization in Upcoming Budget
12m ago
UBS Says Kratos Defense & Security Solutions, Inc. (KTOS) Growth Fully Reflected in Current Valuation
18m ago
Here’s How Much a $1K Investment in Nike’s Stock 10 Years Ago Would Be Worth Today
18m ago